Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1994;2(4):154–161. doi: 10.1155/S1064744994000578

Case-control Analysis of Clostridium difficile—Associated Diarrhea on a Gynecologic Oncology Service

Steven E Waggoner 1,2,✉, James Barter 1, Gregorio Delgado 1,3, Willard Barnes 1
PMCID: PMC2364387  PMID: 18475384

Abstract

Objective: The incidence, morbidity, and risk factors associated with Clostridium difficile-associated diarrhea (CDAD) were studied in a group of gynecologic oncology patients.

Methods: A case-control analysis of gynecologic oncology patients with CDAD was carried out from August 1986 through January 1989 in a university medical center.

Results: One hundred twenty-three stool samples were tested for C. difficile using the CDT latex agglutination test (Marion Diagnostics, Kansas City, MO). Thirty episodes of CDAD developed in 23 patients. From August 1986 through July 1988, the incidence was stable at 1.5 episodes/100 admissions. From August 1988 through January 1989, the incidence increased to 9.9 episodes/100 admissions (P = 0.005). Compared with patients with nonspecific antibiotic-associated diarrhea, the study patients were hospitalized longer prior to the development of symptoms (mean 15.2 vs. 9.2 days, P = 0.006) and were admitted more frequently with diarrhea (37% vs. 11%, P = 0.015). The rates of surgery, chemotherapy, and radiation therapy were similar. Fever (57% vs. 14%, P < 0.001), abdominal pain (40% vs. 6%, P < 0.001), bloody stools (27% vs. 3%, P = 0.006), and leukocytosis (64% vs. 26%, P = 0.011) were more common among the study cases. The duration, indication, and number of antibiotics administered were similar, though once started, the mean time to symptoms was longer in the study cases (13.7 vs. 6.1 days, P = 0.004). Seven relapses, 1 death, and 1 unplanned colostomy occurred among women with CDAD.

Conclusions: C. difficile is a serious cause of nosocomial morbidity in gynecologic oncology patients. Diarrhea developing after antibiotic exposure is more likely to be associated with C. difficile in patients whose symptoms develop several days after completing antibiotics and in patients with a history of CDAD.

Full Text

The Full Text of this article is available as a PDF (643.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronsson B., Möllby R., Nord C. E. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis. 1985 Mar;151(3):476–481. doi: 10.1093/infdis/151.3.476. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G., Taylor N. S., Chang T., Dzink J. Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521–2526. doi: 10.1093/ajcn/33.11.2521. [DOI] [PubMed] [Google Scholar]
  3. Block B. S., Mercer L. J., Ismail M. A., Moawad A. H. Clostridium difficile-associated diarrhea follows perioperative prophylaxis with cefoxitin. Am J Obstet Gynecol. 1985 Dec 15;153(8):835–838. doi: 10.1016/0002-9378(85)90685-4. [DOI] [PubMed] [Google Scholar]
  4. Brown E., Talbot G. H., Axelrod P., Provencher M., Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990 Jun;11(6):283–290. doi: 10.1086/646173. [DOI] [PubMed] [Google Scholar]
  5. Brunetto A. L., Pearson A. D., Craft A. W., Pedler S. J. Clostridium difficile in an oncology unit. Arch Dis Child. 1988 Aug;63(8):979–981. doi: 10.1136/adc.63.8.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burdon D. W., George R. H., Mogg G. A., Arabi Y., Thompson H., Johnson M., Alexander-Williams J., Keighley M. R. Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. J Clin Pathol. 1981 May;34(5):548–551. doi: 10.1136/jcp.34.5.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cudmore M. A., Silva J., Jr, Fekety R., Liepman M. K., Kim K. H. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med. 1982 Feb;142(2):333–335. [PubMed] [Google Scholar]
  8. Fekety R., Shah A. B. Diagnosis and treatment of Clostridium difficile colitis. JAMA. 1993 Jan 6;269(1):71–75. [PubMed] [Google Scholar]
  9. Fekety R., Silva J., Kauffman C., Buggy B., Deery H. G. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med. 1989 Jan;86(1):15–19. doi: 10.1016/0002-9343(89)90223-4. [DOI] [PubMed] [Google Scholar]
  10. Gebhard R. L., Gerding D. N., Olson M. M., Peterson L. R., McClain C. J., Ansel H. J., Shaw M. J., Schwartz M. L. Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis. Am J Med. 1985 Jan;78(1):45–48. doi: 10.1016/0002-9343(85)90460-7. [DOI] [PubMed] [Google Scholar]
  11. Gerding D. N., Olson M. M., Peterson L. R., Teasley D. G., Gebhard R. L., Schwartz M. L., Lee J. T., Jr Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med. 1986 Jan;146(1):95–100. [PubMed] [Google Scholar]
  12. Gilligan P. H., McCarthy L. R., Genta V. M. Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol. 1981 Jul;14(1):26–31. doi: 10.1128/jcm.14.1.26-31.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grube B. J., Heimbach D. M., Marvin J. A. Clostridium difficile diarrhea in critically ill burned patients. Arch Surg. 1987 Jun;122(6):655–661. doi: 10.1001/archsurg.1987.01400180037007. [DOI] [PubMed] [Google Scholar]
  14. Heard S. R., O'Farrell S., Holland D., Crook S., Barnett M. J., Tabaqchali S. The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis. 1986 Jan;153(1):159–162. doi: 10.1093/infdis/153.1.159. [DOI] [PubMed] [Google Scholar]
  15. Kaatz G. W., Gitlin S. D., Schaberg D. R., Wilson K. H., Kauffman C. A., Seo S. M., Fekety R. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988 Jun;127(6):1289–1294. doi: 10.1093/oxfordjournals.aje.a114921. [DOI] [PubMed] [Google Scholar]
  16. Kelly M. T., Champagne S. G., Sherlock C. H., Noble M. A., Freeman H. J., Smith J. A. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea. J Clin Microbiol. 1987 Jul;25(7):1244–1247. doi: 10.1128/jcm.25.7.1244-1247.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McFarland L. V., Mulligan M. E., Kwok R. Y., Stamm W. E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989 Jan 26;320(4):204–210. doi: 10.1056/NEJM198901263200402. [DOI] [PubMed] [Google Scholar]
  18. Mogg G. A., Keighley M. R., Burdon D. W., Alexander-Williams J., Youngs D., Johnson M., Bentley S., George R. H. Antibiotic-associated colitis--a review of 66 cases. Br J Surg. 1979 Oct;66(10):738–742. doi: 10.1002/bjs.1800661017. [DOI] [PubMed] [Google Scholar]
  19. Nolan N. P., Kelly C. P., Humphreys J. F., Cooney C., O'Connor R., Walsh T. N., Weir D. G., O'Briain D. S. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut. 1987 Nov;28(11):1467–1473. doi: 10.1136/gut.28.11.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Novak E., Lee J. G., Seckman C. E., Phillips J. P., DiSanto A. R. Unfavorable effect of atropine-diphenoxylate (Lomotil) therapy in lincomycin-caused diarrhea. JAMA. 1976 Apr 5;235(14):1451–1454. [PubMed] [Google Scholar]
  21. Panichi G., Pantosti A., Gentile G., Testore G. P., Venditti M., Martino P., Serra P. Clostridium difficile colitis in leukemia patients. Eur J Cancer Clin Oncol. 1985 Oct;21(10):1159–1163. doi: 10.1016/0277-5379(85)90008-2. [DOI] [PubMed] [Google Scholar]
  22. Peterson L. R., Olson M. M., Shanholtzer C. J., Gerding D. N. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis. 1988 Jun;10(2):85–91. doi: 10.1016/0732-8893(88)90045-4. [DOI] [PubMed] [Google Scholar]
  23. Pierce P. F., Jr, Wilson R., Silva J., Jr, Garagusi V. F., Rifkin G. D., Fekety R., Nunez-Montiel O., Dowell V. R., Jr, Hughes J. M. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis. 1982 Feb;145(2):269–274. doi: 10.1093/infdis/145.2.269. [DOI] [PubMed] [Google Scholar]
  24. Roda P. I. Clostridium difficile colitis induced by cytarabine. Am J Clin Oncol. 1987 Oct;10(5):451–452. doi: 10.1097/00000421-198710000-00017. [DOI] [PubMed] [Google Scholar]
  25. Siegel D. L., Edelstein P. H., Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA. 1990 Feb 16;263(7):979–982. [PubMed] [Google Scholar]
  26. Talbot R. W., Walker R. C., Beart R. W., Jr Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. Br J Surg. 1986 Jun;73(6):457–460. doi: 10.1002/bjs.1800730614. [DOI] [PubMed] [Google Scholar]
  27. Tedesco F. J. Pseudomembranous colitis: pathogenesis and therapy. Med Clin North Am. 1982 May;66(3):655–664. doi: 10.1016/s0025-7125(16)31413-4. [DOI] [PubMed] [Google Scholar]
  28. Thibault A., Miller M. A., Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991 Jun;12(6):345–348. doi: 10.1086/646354. [DOI] [PubMed] [Google Scholar]
  29. Young G. P., Bayley N., Ward P., St John D. J., McDonald M. I. Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors. Med J Aust. 1986 Mar 17;144(6):303–306. doi: 10.5694/j.1326-5377.1986.tb128379.x. [DOI] [PubMed] [Google Scholar]
  30. Zimmerman R. K. Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission. Infect Control Hosp Epidemiol. 1991 Feb;12(2):96–100. doi: 10.1086/646294. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES